Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
Q4 2023 vs. Q3 2023
How the institutions holding Cidara Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 52 | 51 | −1 |
| Shares | 24.1M | 23.2M | −894.5K (−3.7%) |
| Value | $22.7M | $18.4M | −$4.28M (−18.9%) |
New holders (5)
Institutions that held Cidara Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 36,681 | $29.1K | 0.00% |
| Jane Street Group, LLC | 13,754 | $10.9K | 0.00% |
| Susquehanna International Group, LLP | 12,886 | $10.2K | 0.00% |
| Wetzel Investment Advisors, Inc. | 4,000 | $3.00K | 0.00% |
| Bank of America Corp | 53 | $42 | 0.00% |
Sold out (6)
Institutions that held Cidara Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| West Family Investments, Inc. | 368,910 | $347.6K |
| Two Sigma Investments, LP | 56,100 | $52.9K |
| Invesco Ltd. | 42,223 | $39.8K |
| Stratos Wealth Partners, LTD. | 36,489 | $34.4K |
| Flagship Harbor Advisors, LLC | 30,011 | $28.3K |
| Mercer Global Advisors Inc | 28,750 | $27.0K |